RAISED CEREBROSPINAL-FLUID NOREPINEPHRINE IN SOME PATIENTS WITH PRIMARY HYPERTENSION

被引:80
作者
EIDE, I
KOLLOCH, R
QUATTRO, VD
MIANO, L
DUGGER, R
VANDERMEULEN, J
机构
[1] UNIV SO CALIF, LOS ANGELES CTY MED CTR, DEPT MED, LOS ANGELES, CA 90033 USA
[2] UNIV SO CALIF, LOS ANGELES CTY MED CTR, DEPT NEUROL, LOS ANGELES, CA 90033 USA
[3] WHITE MEM MED CTR, DEPT MED, LOS ANGELES, CA 90033 USA
关键词
Cerebrospinal fluid; Neurogenic mechanisms; Norepinephrine; Primary hypertension;
D O I
10.1161/01.HYP.1.3.255
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
To test whether central neurogenic factors participate in blood pressure elevation in primary hypertension, we studied the concentrations of: norepinephrine, epinephrine and dopamine-beta-hydroxylase (DBH) in cerebrospinal fluid (CSF); and norepinephrine, epinephrine, DBH and plasma renin activity (PRA) in plasma of 22 subjects (seven with primary hypertension, 11 normotensive patients with non-systemic neurological disorders, and four with secondary hypertension). Plasma and CSF norepinephrine (NE) were increased in primary hypertensives compared to normotensives. Cerebrospinal fluid norepinephrine was related to diastolic blood pressure, and systolic blood pressure when normotensive and primary hypertensives were taken together. The CSF norepinephrine of primary hypertensive patients was correlated with natural log PRA. The CSF norepinephrine was correlated inversely with age in primary hypertensive patients but not in the normotensive subjects. The low CSF norepinephrine and epinephrine, despite markedly increased plasma NE and epinephrine, in two patients with pbeochromocytoma, indicate a blood-brain barrier for these neurohormones. The observations support the view that the central sympathetic nervous system is involved in the pathogenesis of primary hypertension, particularly in younger patients. (Hypertension I: 255-260, 1979). © 1979 American Heart Association, Inc.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 30 条
  • [1] CUMMINS BH, 1973, BRIT J SURG, V60, P910
  • [2] CIRCULATING CATECHOLAMINE LEVELS IN HUMAN AND EXPERIMENTAL HYPERTENSION
    DECHAMPLAIN, J
    FARLEY, L
    COUSINEAU, D
    VANAMERINGEN, MR
    [J]. CIRCULATION RESEARCH, 1976, 38 (02) : 109 - 114
  • [3] DEQUATTR.V, 1972, LANCET, V1, P806
  • [4] INCREASED PLASMA CATECHOLAMINES IN HIGH RENIN HYPERTENSION
    DEQUATTRO, V
    CAMPESE, V
    MIURA, Y
    MEIJER, D
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1976, 38 (06) : 801 - 804
  • [5] ROLE OF CENTRAL AND PERIPHERAL ADRENERGIC MECHANISMS IN NEUROGENIC HYPERTENSION PRODUCED BY BRAIN-STEM LESIONS IN RAT
    DOBA, N
    REIS, DJ
    [J]. CIRCULATION RESEARCH, 1974, 34 (03) : 293 - 301
  • [6] ENGELMAN K, 1970, CIRC RES, V27, pI141
  • [7] ESLER M, 1976, LANCET, V2, P115
  • [8] MILD HIGH-RENIN ESSENTIAL HYPERTENSION - NEUROGENIC HUMAN HYPERTENSION
    ESLER, M
    JULIUS, S
    ZWEIFLER, A
    RANDALL, O
    HARBURG, E
    GARDINER, H
    DEQUATTRO, V
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1977, 296 (08) : 405 - 411
  • [9] PLASMA DOPAMINE BETA-HYDROXYLASE AND NORADRENALINE AMOUNTS IN ESSENTIAL HYPERTENSION
    GEFFEN, LB
    RUSH, RA
    LOUIS, WJ
    DOYLE, AE
    [J]. CLINICAL SCIENCE, 1973, 44 (06) : 617 - 620
  • [10] GLOWINSK.J, 1966, PHARMACOL REV, V18, P1201